iLABMED:A Translational Medical Journal Embracing a New EraOA
The third anniversary of iLABMED will be commemorated in June 2026.The editorial leadership extends sincere appreciation to all authors,reviewers,editors,and readers for their continued support and contributions.Over the past year,the journal has made steady progress across multiple dimensions,reflecting its growing academic influence and sustained commitment to translational medicine.
Tetsuya Asakawa;Yi-Wei Tang;Hongzhou Lu
Institute of Neurology,National Clinical Research Center for Infectious Diseases,Shenzhen Third People''s Hospital,Shenzhen,Guangdong,ChinaCollege of Public Health,Chongqing Medical University,Chongqing,ChinaDepartment of Infectious Diseases,National Clinical Research Center for Infectious Diseases,Shenzhen Third People''s Hospital,Shenzhen,Guangdong,China
医药卫生
translational medicineacademic influenceeditorsreadersjournal anniversaryeditorial leadershipreviewers
《iLABMED》 2026 (1)
P.1-4,4
supported by the Shenzhen Science and Technological Foundation(Grant JSGG20220301090005007)the Shenzhen High-level Hospital Construction Fund(Grant 23274G1001).
评论